Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | LOreal SA | 1,095 |
| 2 | Genentech Inc | 537 |
| 3 | Symrise AG | 387 |
| 4 | Kenvue Brands LLC | 350 |
| 5 | Pfizer Inc | 334 |
| 6 | DSM IP Assets BV | 331 |
| 7 | BASF SE | 322 |
| 8 | Pfizer Corp SRL | 297 |
| 9 | Nestec SA | 277 |
| 10 | Nicoventures Trading Ltd | 274 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 37,920 |
| 2 | A61P | Therapeutic activity (drug indications) | 27,770 |
| 3 | A61Q | Cosmetics, personal care | 12,368 |
| 4 | A23L | Foods and beverages (general) | 8,836 |
| 5 | A23V | Foods, foodstuffs - indexing scheme | 6,272 |
| 6 | C07D | Heterocyclic compounds | 5,667 |
| 7 | C12N | Microorganisms, enzymes | 5,383 |
| 8 | C07K | Peptides | 3,813 |
| 9 | G01N | Investigating / analysing materials | 3,373 |
| 10 | Y02A | Climate change adaptation | 3,249 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Pharmaceutical formulations of resveratrol and methods of use thereof | 2002 | Pharmascience Inc | 200 |
| Administration of resveratrol to prevent or treat restenosis following coronary intervention | 2001 | Pharmascience Inc | 182 |
| THE USE OF RESVERATROL TO REGULATE EXPRESSION OF APOLIPOPROTEIN A1 | 2004 | RESVERLOGIX, INC. | 117 |
| Administration of resveratrol to treat inflammatory respiratory disorders | 2005 | Ip2ipo Innovations Ltd | 107 |
| Compositions based on resveratrol | 2003 | CAUDALIE | 97 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Sirtuins and Resveratrol in Medicine | 147 |
| 2 | Phytochemicals and Antioxidant Activities | 7 |
| 3 | Curcumin's Biomedical Applications | 6 |
| 4 | Heme Oxygenase-1 and Carbon Monoxide | 6 |
| 5 | Autophagy in Disease and Therapy | 5 |
| 6 | Cancer, Hypoxia, and Metabolism | 5 |
| 7 | Mitochondrial Function and Pathology | 5 |
| 8 | Adipose Tissue and Metabolism | 4 |
| 9 | Genomics, phytochemicals, and oxidative stress | 4 |
| 10 | Nutrition, Genetics, and Disease | 4 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Dipak K. Das | University of Connecticut | 46 |
| 2 | A Bertelli | University of Milan | 30 |
| 3 | Dominique Delmas | Université de Bourgogne | 27 |
| 4 | John M. Pezzuto | University of Hawaii at Hilo | 23 |
| 5 | María P. Portillo | University of the Basque Country | 21 |
| 6 | Jing Wang | Zhejiang University | 19 |
| 7 | Joseph Wu | New York Medical College | 19 |
| 8 | Jia Liu | Dalian Medical University | 16 |
| 9 | Agnes M. Rimando | Agricultural Research Service | 15 |
| 10 | Beata Olas | University of Łódź | 15 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Dose translation from animal to human studies revisited | 2007 | 6297 | Sirtuins and Resveratrol in Medicine |
| Resveratrol improves health and survival of mice on a high-calorie diet | 2006 | 4236 | Genetics, Aging, and Longevity in Model Organisms |
| Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α | 2006 | 3978 | Sirtuins and Resveratrol in Medicine |
| Therapeutic potential of resveratrol: the in vivo evidence | 2006 | 3888 | Sirtuins and Resveratrol in Medicine |
| Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan | 2003 | 3762 | Genetics, Aging, and Longevity in Model Organisms |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular structure and chemical composition of resveratrol?
Which organizations hold the most patents related to resveratrol?
What are the primary research topics associated with resveratrol publications?
Which researchers have published the most papers on resveratrol?
What patent classifications dominate resveratrol-related intellectual property?